Clinical Trials Sponsored by Palmaz Scientific

Total 2446 results

Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL) (MMCI)

Diffuse Large B Cell Lymphoma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors (BASKET PSMA)

Prostate-specific Membrane Antigen | mCRPC or Advanced/Metastatic Solid Tumors

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer. (COREVAX-1)

Stage IV Colorectal Cancer | Curative Resection

Italy
Istituti Clinici Scientifici Maugeri SpA
Istituto Universitario di Studi Superiori Pavia

Completed

Executive Functioning and Sleep Fragmentation in COVID-19 Patients

COVID-19 | Healthy Volunteers

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC. (IRSTB030)

Prostate Cancer | Metastatic Cancer | Castration-resistant Prostate Cancer | Circulating Tumor Cells

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor

Neoplasms, Germ Cell and Embryonal

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib (INNOVATE)

Hepatocellular Carcinoma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors (Lu-Ca-S)

Gastro-entero-pancreatic Neuroendocrine Tumors

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia (Immune-AML)

Acute Myeloid Leukemia

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Italian Non-Interventional Study of FLT3 Mutated AML Patients (FLAM)

AML | FLT3-ITD Mutation | FLT3-TKD Mutation

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Emilia-Romagna Surgical Colorectal Cancer Audit- ESCA (ESCA)

Colorectal Cancer | Surgery | Financial Benefit | Auditing Activity

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.

Pancreatic Neoplasm | Gastric Neoplasm

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI (PREV)

Metastatic Renal Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer (GastroDOC)

Gastric Cancer | Locally Advanced Malignant Neoplasm

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.

Unresectable Pancreatic Cancer | Locally Advanced Pancreatic Cancer | Nonmetastatic Pancreatic Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Not yet recruiting

Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer (ARTHE)

Breast Cancer
Istituto Scientifico Romagnolo per lo Studio e...

Not yet recruiting

"Receptor Radionuclide Therapy With 177Lu-DOTATOC (LUFOR)

Neuroendocrine Tumors | Pheochromocytoma | Paraganglioma
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer (OVERPASS)

Pancreatic Cancer

Italy
Istituti Clinici Scientifici Maugeri SpA
Istituto Universitario di Studi Superiori Pavia

Recruiting

Neural Bases of Social Cognitive Processing in Healthy Individuals

Healthy Volunteers

Italy
Istituti Clinici Scientifici Maugeri SpA
Istituto Universitario di Studi Superiori Pavia

Recruiting

Unconscious Processing in Decision-making

Healthy Volunteers

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology

Cancer | Solid Tumor | Hematologic Malignancy | Oral Drug Administration

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Not yet recruiting

Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients With Prostate Cancer. (F-PSMA)

Prostate Cancer | 18F-PSMA

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging. (BIOPSTAGE)

Prostate Cancer | Diagnosis | 68Ga-PSMA PET/CT Guided Prostate Biopsy | Mp-3TMRI Guided Prostate Biopsy | TNM Staging

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. (HBO-RT)

High Grade Glioma | Malignant Glioma | Recurrent Glioma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma (MesoRT)

Malignant Pleural Mesothelioma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTATATE in Advanced Gastro-entero Pancreatic Neuroendocrine Tumors (LUNET)

Neuroendocrine Tumors

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) (COLORE)

Rectal Carcinoma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study (ABSIDE)

Malignant Melanoma of Skin Stage III | Malignant Melanoma of Skin Stage IV

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Radiotherapy as an Immunological Booster in Patients With Metastatic Melanoma or Renal Cell Carcinoma Treated With High-dose Interleukin-2 (IL2HD)

Metastatic Renal Cell Cancer | Malignant Melanoma, Metastatic

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas (SENECA)

Neuroendocrine Carcinoma

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients. (ACDC)

Malignant Melanoma | Adjuvant Drug Therapy | Vaccin Therapy

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

Optimizing the Interval Between Cycles of PRRT With 177lu-dotatate in sstr2 Positive Tumors (LUTHREE)

Neuroendocrine Tumors

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas (itTRIOlym)

Recurrent Disease | DLBCL | MCL

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients

Colorectal Cancer Metastatic

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.

Women With Primary Breast Cancer

Italy
Istinye University
Yasemin Çırak; Gül Deniz YILMAZ YELVAR; Serap İNAL; Nurgül DÜRÜSTKAN ELBAŞI

Completed

The Effect of Neurophysiological Facilitation Techniques on Respiratory in Stroke

Hemiplegia,Stroke, Respiratory, Neurophysiological Facilitation Techniques

Turkey
Istituti Clinici Scientifici Maugeri SpA
Società Italiana Cardiologia Ospedalità Accreditata (SICOA)

Recruiting

Therapeutic Strategy With Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease (PRODOAC)

Atrial Fibrillation

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors (FAPI)

Solid Tumor, Unspecified, Adult

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST) (LUST)

Prostate Cancer

Italy
Istituti Clinici Scientifici Maugeri SpA
Istituto Universitario di Studi Superiori Pavia

Recruiting

Neural Bases of Decision-making in Healthy Individuals

Healthy Volunteers

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Partial Breast Re-irradiation in Women in Women With Locally Recurrent Breast Cancer Previously Treated With Conservative Surgery and Whole Breast Irradiation (PBReI)

Breast Cancer | Recurrent

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Medication Reconciliation in Oncologic Patients (PROF2)

Medication Reconciliation

Italy
Istituti Clinici Scientifici Maugeri SpA
Istituto Universitario di Studi Superiori Pavia

Recruiting

Effort-based Decision-making and CPAPadherence

Obstructive Sleep Apnea | Adherence

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

A Phase II Study on Adjuvant Vaccination With Dendritic Cells Loaded With Autologous Tumor Homogenate in Resected Stage IV Rare Cancers. (RaC-Ad)

Soft Tissue Sarcoma | Neuroendocrine Tumors | Vaccination | Head Neck Tumors | Rare Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies (MESOVAX)

Progressive Disease | Mesothelioma, Malignant | Advanced Cancer | PD-L1 Negative

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC) (LU-PSMA)

Metastatic Castration Resistant Prostate Cancer | 68Ga-PSMA PET/CT Positive

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Active, not recruiting

68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated (GaPSMA)

Prostate Cancer | 68Ga-PSMA HBED-PET/CT

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA) (WB-LuPSMA)

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy (THRIP)

Prostate Adenocarcinoma | Radiotherapy; Complications | Tomotherapy

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

3 Tesla Magnetic Resonance Guided High Intensity Focused Ultrasound in the Treatment of Pain From Bone Metastases of Solid Tumors (HIFU-Bone)

Solid Tumors

Italy

Clinical Trials Sponsored by Palmaz Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations